Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage

Purpose: Low-dose metronomic chemotherapy can achieve disease control with reduced toxicity compared to conventional chemotherapy in maximum tolerated dose. Characterizing the gut microbiota of cancer patients under different dosage regimens may describe a new role of gut microbiota associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Xiuwen, Ma, Fei, Sun, Xiaoying, Li, Chunxiao, Li, Lixi, Liang, Fang, Li, Shaochuan, Yi, Zongbi, Liu, Binliang, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358584/
https://www.ncbi.nlm.nih.gov/pubmed/32733788
http://dx.doi.org/10.3389/fonc.2020.00902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358584/
https://www.ncbi.nlm.nih.gov/pubmed/32733788
http://dx.doi.org/10.3389/fonc.2020.00902

Ejemplares similares